White spot lesions during multibracket appliance treatment : a challenge for clinical excellence

Loading...
Thumbnail Image

Date

Advisors/Reviewers

Further Contributors

Contributing Institutions

Publisher

Journal Title

Journal ISSN

Volume Title

Publisher

License

Abstract

The present study aimed to investigate the incidence and further course of White Spot Lesions (WSL) during and after multibrackets appliance (MB) treatment. All former MB-patients finishing orthodontic treatment at the University of Giessen between 1996 and 2006 were screened. The first 400 patients (168 male, 232 female) meeting the in-clusion criteria - all upper front teeth (UFT) fully erupted and visible on before treatment photographs, no fillings or structural abnormalities, duration MB treatment greater-than-or-equal 1 year, retention period greater-than-or-equal 1 year - were selected. The average age of the patients was 13.7 years (SD 3.5) and the average MB treatment time 1.9 years (SD 3.6). A modification of the White Spot Index by Gorelick et al. (1982) was used to evaluate the labial surface of the four front teeth in the upper incisor area on intra-oral photos before (T0), after treatment (T1) and after the end of retention (T2). The results revealed the following: Before treatment 32.3% of the patients exhibited WSL on 19.7% of the UFT. After MB treatment 73.5% of the patients and 57.4% of the UFT presented WSL. The incidence of WSL during MB treatment amounted to 60.9% of the patients. The majority of the UFT (41.2%) had mild lesions while the remaining UFT were af-fected severely with (3.8%) or without (12.4%) cavitations at T1. Only 26.5% of the patients were free of WSL both at T0 and at T1. After the retention phase the majority of the lesions (68.4%) were improved, 20.7% were unchanged and 10.9% had worsened. Male WSL-patients tended to show more severe WSL than females. There was a tendency for an increased WSL development during the adolescent com-pared to pre- and post-adolescent age groups. It was concluded, that using only general prophylactic measures, new WSL developing on the UFT during MB treatment remain to be a frequent undesired side-effect affecting 60.9% of the patients counteracting our efforts for clinical excellence.

Link to publications or other datasets

Description

Notes

Original publication in

Original publication in

Anthology

URI of original publication

Forschungsdaten

Series

Citation